AddLife AB Class B (0REZ.L) Stock Analysis & Winston Score
AddLife AB is a Swedish company that distributes medical and laboratory equipment across Europe. It sells products like diagnostic tools, surgical instruments, and lab supplies to hospitals, clinics, and research laboratories. The company acts as a middleman between manufacturers and healthcare providers, and it has grown largely by acquiring smaller specialty distributors over time. AddLife makes money by buying products from manufacturers and reselling them at a markup, earning a gross margin of around 38%. It operates mainly in the Nordic countries and broader Europe, with hundreds of employees spread across many subsidiaries. The company's competitive edge comes from its network of specialized local businesses, which build deep relationships with customers in niche medical and life science markets. The main risk is that its acquisition-driven growth strategy depends on finding and integrating new companies successfully, and rising interest rates or a slowdown in healthcare spending could pressure both deal activity and profit margins.
Winston Score: 50/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (9/30)
- Growth: Strong (15/20)
- Cash Flow: Strong (8/10)
- Stability: Good (5/10)
- Valuation: Mixed (4/10)
- Ownership: Good (8/15)
Key Facts
Price: $162.50
Market Cap: $19.8B
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: London Stock Exchange


